Our website will be undergoing scheduled maintenance and unavailable from Friday, January 20th at 2pm PT to Saturday, January 21st at 12am PT. We apologize for the inconvenience.


Anti-Human IL-13 PE

Also known as: Interleukin-13, NC30

Clone: 85BRD

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# 12-7136

Cat. No. Size
12-7136-41 25 tests
12-7136-42 100 tests
Please inquire about custom configurations or bulk packaging.

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.


Data for Anti-Human IL-13 PE.

Normal human peripheral blood cells were unstimulated (left) or stimulated for 5 hours with the Cell...View More

  • Data for Anti-Human IL-13 PE.
  • Data for Anti-Human IL-13 PE.
Description

Description: The 85BRD monoclonal antibody reacts with human interleukin-13 (IL-13). IL-13, also known as NC30, is a 12.5 kDa protein secreted by activated T helper cells, CD8+ T cells, and NK cells. The biological activities of IL-13 include suppression of macrophage cytotoxic activity, upregulation of IL-1RA expression and suppression of inflammatory cytokine expression.

Details
Host Mouse
Isotype IgG2b, kappa
Reactivity Human
Conjugate PE
Laser Blue Laser, Green Laser, Yellow-Green Laser
Emit 578 nm
Excite 488 - 561 nm
Reported Applications Intracellular Staining Followed by Flow Cytometric Analysis
Documentation
TDS Link Download TDS
Additional Formats
Cat. No. Name Excite Emit Application Reg.
11-7136 Anti-Human IL-13 FITC 488 nm 520 nm FC RUO
Related Products
Cat. No. Name Excite Emit Application Reg.
00-4980 Protein Transport Inhibitor Cocktail (500X) FC, FA GPR
17-0049 Anti-Human CD4 APC 633 - 647 nm 660 nm FC RUO
00-4975 Cell Stimulation Cocktail (plus protein transport inhibitors) (500X) FC, FA GPR
12-4732 Mouse IgG2b K Isotype Control PE 488 - 561 nm 578 nm FC RUO
88-8824 Intracellular Fixation & Permeabilization Buffer Set FC GPR
References

References: Divekar AA, Khanna D, Abtin F, Maranian P, Saggar R, Saggar R, Furst DE, Singh RR. Reatment with imatinib results in reduced IL-4-producing T cells, but increased CD4(+) T cells in the broncho-alveolar lavage of patients with systemic sclerosis. Clin Immunol. 2011 Dec;141(3):293-303

Griffioen M, Borghi M, Schrier PI, Osanto S, Schadendorf D. Analysis of T-cell responses in metastatic melanoma patients vaccinated with dendritic cells pulsed with tumor lysates. Cancer Immunol Immunother. 2004 Aug;53(8):715-22.

van Halteren AG, van Etten E, de Jong EC, Bouillon R, Roep BO, Mathieu C.Redirection of human autoreactive T-cells Upon interaction with dendritic cells modulated by TX527, an analog of 1,25 dihydroxyvitamin D(3). Diabetes. 2002 Jul;51(7):2119-25.

Martin S, Wolf-Eichbaum D, Duinkerken G, Scherbaum WA, Kolb H, Noordzij JG, Roep BO. Development of type 1 diabetes despite severe hereditary B-lymphocyte deficiency. N Engl J Med. 2001 Oct 4;345(14):1036-40

Chomarat P , Banchereau J. Interleukin-4 and interleukin-13: their similarities and discrepancies. Int Rev Immunol. 1998;17(1-4):1-52.


View More Products

AntigensCell TypeFormatsMiscellaneous